Carter, PharmD, is a clinical pharmacist and freelance health writer who currently works in a managed care setting, performing quality audits on utilization management
Within the context of the totality of evidence on iQOS, we remain confident in our results to date, which demonstrate that iQOS is likely to be less harmful than cigarettes.
State-backed insurance plans like Californias FAIR Plan have seen surging enrollment as private carriers reduce exposure
On December 27, 2020, as a part of the Consolidated Appropriations Act, 2021, Congress had conversations to include e-cigarettes and all vaping products in a nationwide mailing ban

How we use your data We collect your information as part of the consultation process: for statistical purposes, for example to understand where the responses are coming from so that DHSC can contact you for further information about your response, if you have given DHSC your email address to reduce the likelihood of individuals being able to submit multiple responses Who we may share your data with Responses may be seen by: DHSC officials running the technical consultation officials from the UK devolved governments and other government departments DHSCs third-party supplier (SocialOptic), which is responsible for running and hosting the online survey Legal basis for processing personal data Under article 6 of the UK General Data Protection Regulation, the lawful bases we rely on for processing this personal data is that the processing is necessary to perform a task in the public interest or for our official functions and the task or function has a clear basis in law